Cargando…
The problem of Mycobacterium abscessus complex: multi-drug resistance, bacteriophage susceptibility and potential healthcare transmission
OBJECTIVES: Mycobacterium abscessus complex is responsible for 2.6–13.0% of all non-tuberculous mycobacterial pulmonary infections and these are notoriously difficult to treat due to the complex regimens required, drug resistance and adverse effects. Hence, bacteriophages have been considered in cli...
Autores principales: | Dedrick, Rebekah M., Abad, Lawrence, Storey, Nathaniel, Kaganovsky, Ari M., Smith, Bailey E., Aull, Haley A., Cristinziano, Madison, Morkowska, Anna, Murthy, Saraswathi, Loebinger, Michael R., Hatfull, Graham F., Satta, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583746/ https://www.ncbi.nlm.nih.gov/pubmed/37364635 http://dx.doi.org/10.1016/j.cmi.2023.06.026 |
Ejemplares similares
-
Nebulized Bacteriophage in a Patient With Refractory Mycobacterium abscessus Lung Disease
por: Dedrick, Rebekah M, et al.
Publicado: (2022) -
The Prophage and Plasmid Mobilome as a Likely Driver of Mycobacterium abscessus Diversity
por: Dedrick, Rebekah M., et al.
Publicado: (2021) -
Unusual prophages in Mycobacterium abscessus genomes and strain variations in phage susceptibilities
por: Amarh, Elizabeth D., et al.
Publicado: (2023) -
Bacteriophage treatment of disseminated cutaneous Mycobacterium chelonae infection
por: Little, Jessica S., et al.
Publicado: (2022) -
Mycobacterium abscessus Strain Morphotype Determines Phage Susceptibility, the Repertoire of Therapeutically Useful Phages, and Phage Resistance
por: Dedrick, Rebekah M., et al.
Publicado: (2021)